Black Diamond Therapeutics: Phase 1 dose-escalation trial results of bdtx-1535 in GBM patients show good safety and tolerability
Black Diamond Therapeutics：针对GBM患者的Bdtx-1535的1期剂量递增试验结果显示出良好的安全性和耐受性
Black Diamond Therapeutics: Phase 1 dose-escalation trial results of bdtx-1535 in GBM patients show good safety and tolerability
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.